Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Austin Lee Resourcing

    Austin Lee Resourcing was founded with a clear sense of purpose to provide a high level service that is efficient, genuine and innovative to both our candidates and our clients. Our objective is to provide informed career advice and opportunities to our candidates and added value to our clients’ global resourcing needs. Our combined expertise in Business Operations, Finance, Healthcare plus Communications helps us deliver this.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    - PMLiVE

    M3 (EU)

    M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

    View Profile

    Digital communications, Medical education, Recruitment and career development

    Company Details

    Austin Lee Resourcing
    North West London, London, N3, United Kingdom
    0208 371 5603
    Contact Austin Lee Resourcing
    Website

     Latest Content from PMHub 

    International Women’s Day 2022

    Press Releases | March 8, 2022 | Mednet

    This year the theme of International Women’s Day is ‘break the bias’, focussing on how our actions in our communities, workplaces, schools and universities can unite our individual actions with...

    How I’m helping to #BreakTheBias: International Women’s Day

    Press Releases | March 8, 2022 | Lucid Group Communications Limited

    What do you think of when you imagine a scientist? Who do you see in a lab coat? Gender stereotypes and assumptions are rife and, as a child, the thought...

    How do doctors want to engage with pharma on new products?

    White Papers and Resources | March 8, 2022 | M3 (EU)

    More than 80% of European doctors agree they are interested in staying up-to-date with new developments about pharmaceutical products. But what influences their choice of treatment and how do they...

    Virtual collaboration tools to reduce “digital overload”

    White Papers and Resources | March 7, 2022 | Impetus Digital

    Considering its impact on our health and productivity, digital overload is clearly something that we need to take seriously.

    Extraordinary lives: advancing change in rare diseases

    Press Releases | March 4, 2022 | Lucid Group Communications Limited

    Rare Disease Day is all about raising awareness and generating change for the 300 million people worldwide living with a rare disease. On this day across the globe, the rare...

    Extraordinary lives: advancing change in rare diseases

    Videos and Podcasts | March 4, 2022 | Lucid Group Communications Limited

    We are extending the conversation for Rare Disease Day by continuing to raise awareness and generate change for the 300 million people worldwide living with a rare disease, their families...

    Stand-out Marketing: How to Stay One Step Ahead in Pharma

    White Papers and Resources | March 4, 2022 | Dice Medical Communications

    What do you need to do in order to stand out from the crowd in Pharma marketing? (Article written February 26th 2022)

    Improving healthcare for rare disease patients

    White Papers and Resources | March 4, 2022 | IGNIFI

    Following on from Rare Disease Day 2022, we decided to take a deeper look into the patient journey of those living with a rare health condition. In this blog, we...

    Gamifying Remote Patient Monitoring

    Videos and Podcasts | March 3, 2022 | Impetus Digital

    Dr. Emilia Molimpakis, CEO & Co-founder of Thymia, shares how their platform uses video games based on neuropsychology, alongside analyses of facial microexpressions and speech, to quickly, accurately, and objectively...

    Fishawack Health expands its value, evidence, and market access capabilities with the acquisition of HEOR consultancy Policy Analysis Inc. (PAI)

    Press Releases | March 3, 2022 | Avalere Health

    Fishawack Health announces its expanded global Value, Evidence, and Access (VEA) capability for biopharmaceutical and medical technology companies, with a suite of end-to-end services spanning product lifecycle, coupled with unsurpassed...